Quest Laboratories (NSE:QUESTLAB) Cash Flow from Investing: ₹349 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:QUESTLAB Quest Laboratories Ltd NSE:QUESTLAB
44 GF Score
Price ₹92.95
! 5 Warning Signs
View Full Analysis

What is Quest Laboratories Cash Flow from Investing?

Quest Laboratories NSE:QUESTLAB +0.05% 44 Cash Flow from Investing is ₹349 Mil as of Mar. 2026. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 44/100. The stock has 5 warning signs investors should review.

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the six months ended in Mar. 2026, Quest Laboratories spent ₹8 Mil on purchasing property, plant, equipment. It gained ₹0 Mil from selling property, plant, and equipment. It spent ₹0 Mil on purchasing business. It gained ₹0 Mil from selling business. It spent ₹0 Mil on purchasing investments. It gained ₹376 Mil from selling investments. It paid ₹0Mil for net Intangibles purchase and sale. And it received ₹6 Mil from other investing activities. In all, Quest Laboratories gained ₹374 Mil on investment activities in financial market and operating subsidiaries for the six months ended in Mar. 2026.


Quest Laboratories  (NSE:QUESTLAB) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Quest Laboratories's purchase of property, plant, equipment for the six months ended in Mar. 2026 was ₹-8 Mil. It means Quest Laboratories spent ₹8 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Quest Laboratories's sale of property, plant, equipment for the six months ended in Mar. 2026 was ₹0 Mil. It means Quest Laboratories gained ₹0 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Quest Laboratories's purchase of business for the six months ended in Mar. 2026 was ₹0 Mil. It means Quest Laboratories spent ₹0 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Quest Laboratories's sale of business for the six months ended in Mar. 2026 was ₹0 Mil. It means Quest Laboratories gained ₹0 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Quest Laboratories's purchase of investment for the six months ended in Mar. 2026 was ₹0 Mil. It means Quest Laboratories spent {stock_data.stock.currency_symbol}}0 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Quest Laboratories's sale of investment for the six months ended in Mar. 2026 was ₹376 Mil. It means Quest Laboratories gained ₹376 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Quest Laboratories's net Intangibles purchase and sale for the six months ended in Mar. 2026 was ₹0 Mil. It means Quest Laboratories paid ₹0 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Quest Laboratories's cash from discontinued investing activities for the six months ended in Mar. 2026 was 0 Mil. It means Quest Laboratories paid ₹0 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Quest Laboratories's cash from other investing activities for the six months ended in Mar. 2026 was ₹6 Mil. It means Quest Laboratories received ₹6 Mil from other investing activities.


Quest Laboratories Cash Flow from Investing Related Terms


Quest Laboratories Cash Flow from Investing Historical Data

* Premium members only.

The historical data trend for Quest Laboratories's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Laboratories Cash Flow from Investing Chart

Quest Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Flow from Investing
Get a 7-Day Free Trial -18.88 -38.24 -50.29 -439.69 349.37

Quest Laboratories Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only -54.69 0.00 0.00 -24.76 374.13
NSE:QUESTLAB
44GF Score
Quest Laboratories Ltd NSE:QUESTLAB
Cash Flow from Investing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quest Laboratories Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Quest Laboratories's Cash Flow from Investing for the fiscal year that ended in Mar. 2026 is calculated as:

Quest Laboratories's Cash Flow from Investing for the quarter that ended in Mar. 2026 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹349 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Investing of ₹349 Mil mean?
Quest Laboratories (NSE:QUESTLAB) has a Cash Flow from Investing of ₹349 Mil as of Mar. 2026. Cash Flow from Investing is the amount of cash earned or paid from investing operations. View historical data for Quest Laboratories and its competitors.
Is Quest Laboratories' Cash Flow from Investing too high?
Quest Laboratories' current Cash Flow from Investing is ₹349 Mil. Overall, Quest Laboratories has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' Cash Flow from Investing compare to LLY and JNJ?
Quest Laboratories' Cash Flow from Investing of ₹349 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Investing for a Drug Manufacturers company?
A good Cash Flow from Investing depends on the Drug Manufacturers industry context. However, Cash Flow from Investing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Investing mean?
A high Cash Flow from Investing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Investing is the amount of cash earned or paid from investing operations. View historical data for Quest Laboratories and its competitors. Quest Laboratories's current Cash Flow from Investing is ₹349 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current Cash Flow from Investing of ₹349 Mil. The current Cash Flow from Investing is ₹349 Mil. Quest Laboratories' overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Investing calculated?
Cash Flow from Investing is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current Cash Flow from Investing is ₹349 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest Laboratories Business Description

Address Sector III, Plot No. 45, Pithampur Industrial Area, Opposite Kissan Pipe Unit 4, District Dhar, Pithampur, Dhar, MP, IND, 454775
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
44GF Score

Get the complete analysis for NSE:QUESTLAB

Cash Flow from Investing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹92.95
Price